SCPA.L Regulatory News (SCPA)

24 November 2016

Scapa Group plc

('Scapa' or 'the Company')

Director Dealing:

Exercise of Options under 2004 and 2011 Performance Share Plan

Scapa, a global supplier of bonding solutions and manufacturer of adhesive-based products for the Healthcare and Industrial markets, announces that it has today issued 825,000 new ordinary shares of 5 pence each in the capital of the Company ('Shares') pursuant to the exercise of options under the 2004 and 2011 Performance Share Plans ('PSP') by an Executive Director of the Company. The Shares have been admitted to trading on AIM in accordance with the Company's block listing.

The Company makes the following disclosures of dealing by Directors:

Mr Heejae Chae, Group Chief Executive, was allotted 825,000 Shares on exercise of the PSP options on 24 November 2016. On 24 November 2016, Mr Chae sold 639,699 Shares at a price per Share of 307.75 pence, primarily to satisfy his tax liabilities in respect of the options. Following the sale, Mr Chae holds 1,127,104 Shares in the Company, representing 0.74% of the issued share capital of the Company.

Total Voting Rights

The Company advises that, following the issue of the new Shares pursuant to the exercise of options under the PSP, the Company's issued share capital is 152,237,544. No Shares are held in treasury. As such, the number of Shares with voting rights is 152,237,544. This figure may be used by shareholders as their denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

For further information:

Scapa Group plc:

Graham Hardcastle +44 (0) 161 301 7400

Group Finance Director/Company Secretary

Numis Securities Limited: +44 (0) 20 7260 1000

Mark Lander

Richard Thomas (Nominated Adviser)